PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
CARA vs. QQQM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

CARA vs. QQQM

Last updated May 20, 2025

Compare and contrast key facts about Cara Therapeutics, Inc. (CARA) and Invesco NASDAQ 100 ETF (QQQM).

QQQM is a passively managed fund by Invesco that tracks the performance of the NASDAQ-100 Index. It was launched on Oct 13, 2020.

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CARA or QQQM.

Correlation

The correlation between CARA and QQQM is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

CARA vs. QQQM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cara Therapeutics, Inc. (CARA) and Invesco NASDAQ 100 ETF (QQQM). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Returns By Period

CARA

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

QQQM

YTD

2.30%

1M

17.54%

6M

4.76%

1Y

16.33%

3Y*

22.74%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Cara Therapeutics, Inc.

Invesco NASDAQ 100 ETF

Risk-Adjusted Performance

CARA vs. QQQM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
CARA
The Risk-Adjusted Performance Rank of CARA is 4242
Overall Rank
The Sharpe Ratio Rank of CARA is 3737
Sharpe Ratio Rank
The Sortino Ratio Rank of CARA is 5050
Sortino Ratio Rank
The Omega Ratio Rank of CARA is 5050
Omega Ratio Rank
The Calmar Ratio Rank of CARA is 3232
Calmar Ratio Rank
The Martin Ratio Rank of CARA is 3939
Martin Ratio Rank
QQQM
The Risk-Adjusted Performance Rank of QQQM is 6262
Overall Rank
The Sharpe Ratio Rank of QQQM is 6363
Sharpe Ratio Rank
The Sortino Ratio Rank of QQQM is 6161
Sortino Ratio Rank
The Omega Ratio Rank of QQQM is 6262
Omega Ratio Rank
The Calmar Ratio Rank of QQQM is 6767
Calmar Ratio Rank
The Martin Ratio Rank of QQQM is 5959
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CARA vs. QQQM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cara Therapeutics, Inc. (CARA) and Invesco NASDAQ 100 ETF (QQQM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Loading data...

Dividends

CARA vs. QQQM - Dividend Comparison

CARA has not paid dividends to shareholders, while QQQM's dividend yield for the trailing twelve months is around 0.58%.

TTM20242023202220212020
CARA
Cara Therapeutics, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%
QQQM
Invesco NASDAQ 100 ETF		0.58%0.61%0.65%0.83%0.40%0.16%

Drawdowns

CARA vs. QQQM - Drawdown Comparison

Loading data...

Volatility

CARA vs. QQQM - Volatility Comparison

Loading data...